People with alopecia areata (AA) have increased proportions of circulating CCR6+ “Th17” and CXCR3+CCR6+ “Th1/17” CD4 T cells, which are elevated significantly more often in individuals with <50% hair loss, indicating that the early stages of the disease may be more immunologically active. Here, CD4 is linked to alopecia areata.